However, in our study, none of the previously identified factors (24–26), including old age, male sex, multiple tumor locations, tumor size > 5 cm, adjuvant temozolomide, presence of residual tumor, astrocytoma histology, and IDH wild-type, were significant predictors of MT. The gene discussed is IDH1; the disease is neoplasm.